Gene · 5883
RAD9A: RAD9 checkpoint clamp component A
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. RAD9A: RAD9 checkpoint clamp component A. Genes, record 5883. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5883
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q99638 | Cell cycle checkpoint control protein RAD9A | 391 | 9 | Ensembl, GeneID, HGNC |
Source UniProt
Patents38
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2025521592 A | 2025-07-10 | 73 | Q99638 | Espacenet |
| KR 1020250028392 A | 2025-02-28 | 73 | Q99638 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 8048 | Q99638 | Espacenet |
| US 11976334 B2 | 2024-05-07 | 197 | Q99638 | Espacenet |
| US 11708396 B2 | 2023-07-25 | 2340 | Q99638 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 71202 | Q99638 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 174173 | Q99638 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 9320 | Q99638 | Espacenet |
| JP 2020508335 A | 2020-03-19 | 197 | Q99638 | Espacenet |
| US 10501513 B2 | 2019-12-10 | 8048 | Q99638 | Espacenet |
1 to 10 of 38
See all 38 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,229
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | RAD9A papers | Newest fiscal year |
|---|---|---|---|
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 24 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 10 | 2025 |
| T32CA009582 | Biochemical and Chemical Training for Cancer Research | 9 | 2025 |
| T32ES007028 | Training Program in Environmental Toxicology | 8 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 6 | 2025 |
| R01CA067985 | DNA Damage Repair by MUTYH and MUTYH Variants Associated with Colorectal Cancer | 6 | 2025 |
| ZIABC006150 | DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs | 6 | 2025 |
| R01GM026017 | Enzymatic Mechanisms of Genetic Recombination | 5 | 2025 |
| R01HD095296 | Coordination of Atr Signaling for Genetic Quality Control, Silencing, and DNA Repair during Meiosis | 5 | 2025 |
| T32ES007059 | Advanced Training in Environmental Health Sciences | 5 | 2025 |
1 to 10 of 1,229Source NIH's project files
See all 1,229 nih grantsPapers1,553
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanistic diversity of clamp loading at small DNA gaps. | J Biol Chem | 2026 | 42575442 | PubTator, text mining | PubMed |
| CTPS1 is an unexplored vulnerability in breast and ovarian cancer. | Theranostics | 2026 | 42559234 | PubTator, text mining | PubMed |
| Distinct ATRX functions cooperate with 9-1-1 and CST complexes to safeguard replication and telomere integrity. | Nat Struct Mol Biol | 2026 | 42380617 | PubTator, text mining | PubMed |
| Co-Phosphoregulatory Network Underlying Functional Coherence of TLK1 and TLK2 Kinase Paralogs. | Int J Mol Sci | 2026 | 42353285 | PubTator, text mining | PubMed |
| A RHNO1-ATR/Chk1 positive feedback loop sustains the DNA replication stress response. | bioRxiv | 2026 | 42239230 | PubTator, text mining | PubMed |
| Slx4 and Fun30/SMARCAD1 coordinate S-phase checkpoint regulation and replication fork protection in response to Top1-DNA crosslinks. | Nucleic Acids Res | 2026 | 41978269 | PubTator, text mining | PubMed |
| Protein arginine methyltransferases in cancer: mechanisms, functions, and therapeutic opportunities. | J Biomed Sci | 2026 | 41928257 | PubTator, text mining | PubMed |
| An updated view on lagging strand DNA replication: implications for the replication stress response. | Cell Cycle | 2026 | 41865289 | PubTator, text mining | PubMed |
| Structural pharmacogenomics of drug-associated SNPs in oral squamous cell carcinoma. | Front Genet | 2026 | 41757266 | PubTator, text mining | PubMed |
| OGG1 and MUTYH DNA Glycosylases, the Dynamic Duo Against 8-Oxoguanine DNA Lesion: Structure, Regulation, and Novel Emerging Roles. | Biomolecules | 2026 | 41750327 | PubTator, text mining | PubMed |
1 to 10 of 1,553
See all 1,553 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/5883
GET https://conductscience.org/api/genes/v1/5883/patents?page=2